Related Experiment Videos
Design of a complement mannose-binding lectin pathway-specific activation system applicable at low serum dilutions
M Harboe1, P Garred, M S Borgen
1Institute of Immunology, University of Oslo and Rikshospitalet University Hospital, Oslo, Norway.
Clinical and Experimental Immunology
|June 1, 2006
Summary
This study developed a specific lectin pathway (LP) activation assay for studying complement system function. The assay enables precise investigation of LP mechanisms and alternative pathway (AP) amplification under physiological conditions.
Area of Science:
- Immunology
- Complement System Biology
Background:
- The alternative pathway (AP) significantly amplifies classical pathway-induced complement activation.
- Understanding specific lectin pathway (LP) activation is crucial for dissecting complement system dynamics.
Purpose of the Study:
- To design a robust system for specific lectin pathway (LP) activation at low serum dilutions.
- To enable the study of LP activation with a fully functional alternative pathway (AP).
Main Methods:
- Enzyme-linked immunosorbent assay (ELISA) using mannan on solid phase to activate complement.
- Comparative analysis of normal human serum (NHS) and sera deficient in MBL, C1q, and C2.
- Utilized C4, C3, and terminal complement complex (TCC) deposition as readouts.
Main Results:
- Optimal LP-specific activation achieved at 0.5 microg mannan/well, minimizing direct AP activation.
- MBL-deficient serum showed no LP activation, which was restored by MBL reconstitution.
- Blocking anti-MBL monoclonal antibody (mAb) abolished complement deposition, confirming LP specificity.
Conclusions:
- A novel, specific LP activation assay was established, functional at low serum dilutions.
- This assay is ideal for studying LP mechanisms and AP amplification in physiological contexts.
- The assay differentiates LP activation from AP-driven complement cascades.